Prophylactic platelet transfusions prior to surgery for people with a low platelet count

Lise J Estcourt1, Reem Malouf2, Carolyn Doree3

  • 1Haematology/Transfusion Medicine, NHS Blood and Transplant, Oxford, UK.

Insights

This review assesses if giving prophylactic platelet transfusions before surgery helps patients with low platelet counts or platelet dysfunction. It aims to determine the clinical effectiveness and safety of this intervention.

Area of Science:

  • Hematology
  • Transfusion Medicine
  • Surgical Care

Background:

  • Patients with thrombocytopenia or platelet dysfunction face increased bleeding risks during surgery.
  • Prophylactic platelet transfusions are a common strategy to mitigate surgical bleeding complications.
  • Evidence on the optimal use and effectiveness of these transfusions is crucial for clinical decision-making.

Purpose of the Study:

  • To evaluate the clinical effectiveness of prophylactic platelet transfusions in surgical patients with low platelet counts or dysfunction.
  • To assess the safety profile of prophylactic platelet transfusions in this patient population.
  • To synthesize current evidence regarding the benefits and harms of pre-operative platelet support.

Main Methods:

  • Systematic review and meta-analysis of randomized controlled trials (RCTs) and observational studies.
  • Inclusion of studies comparing prophylactic platelet transfusions versus no transfusions or alternative management strategies.
  • Assessment of clinical outcomes including bleeding events, transfusion requirements, and surgical site complications.

Main Results:

  • Data synthesis will focus on comparing key efficacy and safety endpoints.
  • Subgroup analyses may explore variations based on platelet count thresholds, transfusion triggers, and underlying causes of platelet dysfunction.
  • The review will identify areas with limited or conflicting evidence.

Conclusions:

  • The findings will inform guidelines on the appropriate use of prophylactic platelet transfusions in surgical settings.
  • Recommendations will address the balance between potential benefits (reduced bleeding) and risks (transfusion reactions, alloimmunization).
  • This review aims to optimize patient outcomes and resource utilization in perioperative care.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.8K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.0K
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
430
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
380